Have a Probiotic - Enzyme patented Technology that is ready for marketing and production. Require $5 million for marketing, production and clinical trials. Technology addresses gastrointestinal ( GI ) distress , sugar alcohol intolerance and lactose intolerance as well as severe conditions such as GERD , ulcers , acid reflux and irritable bowel syndrome ( IBS ). HUGE financial potential as well as the benefit of helping the millions of people who suffer from these GI maladies. Serious inquiries only please from accredited investors. Thank You.
Information sharing on anything related to investment, stock market, mutual funds, 401K, RRSP